Alvotech Files September 2025 6-K Report
Ticker: ALVOW · Form: 6-K · Filed: Sep 22, 2025 · CIK: 1898416
| Field | Detail |
|---|---|
| Company | Alvotech (ALVOW) |
| Form Type | 6-K |
| Filed Date | Sep 22, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, corporate-update
TL;DR
Alvotech filed its monthly 6-K report on 9/22/25, confirming its status and Luxembourg base.
AI Summary
Alvotech, a biopharmaceutical company, filed a Form 6-K on September 22, 2025, reporting for the month of September 2025. The company, incorporated in Luxembourg, operates in the biological products sector and uses the standard industrial classification code 2836. Alvotech previously operated under the name Alvotech Lux Holdings S.A.S. before changing its name on December 9, 2021.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding Alvotech's ongoing operations and corporate status as a foreign private issuer.
Risk Assessment
Risk Level: low — This is a routine filing (Form 6-K) that does not contain new material financial or operational information.
Key Players & Entities
- Alvotech (company) — Filer of the report
- 001-41421 (company) — SEC File Number
- Alvotech Lux Holdings S.A.S. (company) — Former company name
- 20250922 (date) — Filing date
- September 2025 (date) — Reporting period
FAQ
What is the primary business of Alvotech?
Alvotech is in the business of Biological Products (No Diagnostic Substances), as indicated by its SIC code 2836.
Where is Alvotech's principal executive office located?
Alvotech's principal executive office is located at 9, Rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg.
What is the SEC file number for Alvotech?
Alvotech's SEC file number is 001-41421.
When did Alvotech change its former name?
Alvotech changed its former name from Alvotech Lux Holdings S.A.S. on December 9, 2021.
What type of report is this filing?
This filing is a Form 6-K, which is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Filing Stats: 562 words · 2 min read · ~2 pages · Grade level 12.5 · Accepted 2025-09-22 16:45:04
Filing Documents
- f6k_092225.htm (6-K) — 9KB
- exh_991.htm (EX-99.1) — 12KB
- exh_992.htm (EX-99.2) — 12KB
- exh_993.htm (EX-99.3) — 16KB
- 0001171843-25-006012.txt ( ) — 51KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Alvotech (Registrant) Date: September 22, 2025 /s/ Tanya Zharov Tanya Zharov General Counsel